Table 1.
Sample and final score for autoimmune pathogenesis of Rift Valley Fever virus retinitis, Kenya*
| Study group | Village | No. | No. tested | No. positive | Immunohistochemical scores | Group average |
|---|---|---|---|---|---|---|
| RVFV retinitis | Masalani | 5 | 8 | 4 | 0.6, 0.7, 2, 2.16, 2.33 | 1.45 |
| Sangailu | 3 | 0.83, 1, 2 | ||||
| RVFV unexposed with retinitis | Masalani | 6 | 9 | 1 | 0, 0.5, 1.25, 1.33, 1.75, 1.75 | 1.24 |
| Sangailu | 3 | 0.14, 1.6, 3 | ||||
| RVFV exposed without retinitis | Masalani | 6 | 9 | 1 | 0, 0, 0.17, 0.5, 1, 1.25 | 0.67 |
| Sangailu | 3 | 0, 0.75, 2.33 | ||||
| RVFV unexposed without retinitis | Masalani | 9 | 17 | 3 | 0, 0, 0.25, 0.25, 0.75, 0.75, 1, 1.5, 2.33 | 1.09 |
| Sangailu | 8 | 0, 1.2, 1.25, 1.25, 1.33, 1.5, 2.33, 3 |
RVFV = Rift Valley Fever virus. The nine positive scores (≥ 2) are indicted in boldface.